Facial clefts in the west of Scotland in the period 1980-1984: epidemiology and genetic diagnoses D R FitzPatrick, P A M Raine, J G Boorman Abstract Two hundred and eighty six cases of cleft lip, cleft palate, or both were identified in a study attempting complete ascertainment of babies with facial clefts born to women resident in the west of Scotland in a five year period beginning 1 January 1980. The total birth prevalence (TBP) of these defects over this period was 1-53 per 1000. The TBP for cleft lip with or without cleft palate (CL[P] was 0-74 per 1000 and for cleft palate (CP) was 0 79 per 1000; 26% of CL[P] and 39-5% of CP cases had one or more major congenital anomaly associated with their facial cleft and in over half of these cases a specific genetic or syndrome diagnosis could be made. In comparison to previous European reports this study shows a high incidence of associated abnormalities and a remarkably low ratio of CL[P]:CP cases.
(J Med Genet 1994;31:126-129) Duncan Guthrie Institute of Medical Genetics, Yorkhill, Glasgow G3 8SJ, UK Cleft lip with or without cleft palate (CL[P] and cleft palate (CP) are aetiologically distinct subgroups of the facial cleft group of anomalies. This distinction has been made on the basis of the different embryological timings of primary and secondary palate closure' and recurrence of the same type of defect within a family.2"5 There are also epidemiological differences between the groups which include an observed racial variation in the birth prevalence of CL[P]-9 but not CP,9"0 an excess of male cases in most reports of the CL[P] group,24101' and a slight female excess in the CP group.'012 The higher incidence of associated congenital anomalies that has been reported in subjects with CP compared to those with CL[P]'314 has also been cited as evidence of distinct aetiologies for these groups.
In spite of the differences between these groups there is evidence suggesting common factors in their aetiology. Woolf'5 has shown a small but convincing increase in the occurrence of CP in the families of a large cohort of patients with CL[P]. Rintala'6 reported a remarkable parallelism in the changes of birth prevalence of CL[P] and CP over a 27 year period in the Finnish population. It has also been noted that families with Van der Woude syndrome (MIM 119300) may have both types of defect associated with lip pits segregating in one pedigree.'7 Finally, a variation in the transforming growth factor a (TGFa) gene has been found to be over-represented in cohorts of unrelated subjects with both CL[P] and CP. [18] [19] [20] [21] Previous reports of facial clefts in Scot-land22 23 have suggested that there is a relatively low incidence of CL[P] and high incidence of CP in this population compared to the European average. In the present study we have attempted complete ascertainment of babies born with facial clefts, within a five year period, to mothers living in the west of Scotland in order to calculate the birth prevalence of each subgroup. Particular attention was paid during the study to the number and nature of associated congenital anomalies and the specific genetic diagnosis in each of the subgroups. Data derived from this study are compared to those reported in other studies of European populations.
Materials and methods
The study population comprised those infants born to mothers whose main residence was within Greater Glasgow, Lanarkshire, Forth Valley, Dumfries and Galloway, Argyll and Clyde, or Ayrshire and Arran Health Boards from 1 January 1980 to 31 December 1984. The index cases were identified through four main sources; neonatal discharge forms, hospital admission records, the Glasgow database for European Registration for Congenital Anomalies and Twins (EUROCAT), and hospital diagnostic indices. Follow up information on index cases with associated abnormalities was obtained from personal examination, hospital records, genetic records, and detailed necropsy reports.
Patients with microforms of facial clefts (bifid uvula and submucous cleft palate) were excluded from the study group as the majority of these defects do not come to medical attention and would, therefore, require a population survey for complete ascertainment.2425 A figure for birth prevalence was calculated, as the common occurrence of facial clefts in early spontaneous abortions26 would make an incidence of these defects very difficult to estimate. Birth prevalence figures were calculated per 1000 total births (0/,,TB) or live births (0/,,LB) and quoted with 95% confidence intervals using the methods of Czeizel and Tusnady.27 Groups were compared using the X2 test and the Yates correction factor was used in the two by two contingency tables (YMX2). Evidence of cyclical trends within the facial clefts groups were assessed using both parametric28 and non-parametric rank sum29 methods. Associated congenital anomalies were assigned to major and minor categories using the guidelines of Smith.30 Interestingly, the female excess in the CP group was most prominent in CP cases without associated abnormalities (m:f= 0-65: 1) and in cases with Pierre-Robin sequence (PRS) without additional abnormalities (m:f 0-36: 1). These differences were not statistically significant. 30 40 27 27 * Highly significant excess of male cases (p < 0 01); CL = cleft lip only; CLP = cleft lip with cleft palate; CL[P] = cleft lip with or without cleft palate; CP = cleft palate only; ICA = cases in which the facial cleft was an isolated congenital anomaly; MCA=cases in which the facial cleft was associated with another major congenital anomaly.
GEOGRAPHICAL AND SEASONAL DISTRIBUTION OF BIRTHS
Case distribution assessed by the Health Board of residence of the mother at the time of birth showed no statistically significant differences in TBP or LBP. There was no evidence of significant seasonal variation or cyclical trend in either group (data not shown). OUTCOME Thirteen of 139 (9-3%) cases in the CL[P] group were stillborn; 10/126 (7-9%) liveborn CL[P] cases had died by 1 January 1990; 8/10 had major associated anomalies; 5/147 (3 4%) cases in the CP group were stillborn; 14/142 (9 7%) of the liveborn children with CP had died by 01/01/90 and all had major associated abnormalities. The proportions of stillbirths and early deaths were not significantly different in the two groups. 
Discussion
Much of the data reported here are similar to those reported from other European populations. In particular, TBP of facial clefts,241631' 32 laterality of lip defects,'0 12 sex ratio differences of the subgroups,'012 and outcome data33 are apparently consistent findings that have been the subject of several excellent reviews'01234 and, therefore, will not be discussed further. Our data, however, do differ significantly from previous reports in the proportion of cases with associated major congenital abnormalities (AMCA) and in the relative frequency of CL[P] and CP in the cohort.
Comparing AMCA incidences between studies is difficult owing to the lack of a rigorous definition of terms used to describe such anomalies35 (for example, uncomplicated micrognathia in Pierre-Robin sequence). However, given these limitations there is a remarkable range in the proportion of cases with AMCA between apparently well ascertained cohorts (table 4, 2-9 to 22-8% for CL[P] and FitzPatrick, Raine, Boorman Pierre-Robin sequence (23) lst/2nd arch syndrome (2) lst/2nd arch syndrome (2) Di George syndrome VATER association Dandy-Walker syndrome 6-5 to 38-0% for CP) with the present study appearing to have the highest incidence of AMCA (26% CL[P] and 39 5% CP) among the groups chosen for comparison. Possible explanations for these differences will be discussed below. The nature of the AMCA reported in these studies is also of importance when comparing these data and may give clues to the pathogenesis of these disorders. This information has, however, been generally less well documented, presumably because of the heterogeneous nature of these anomalies. In the present study 55% (58% CL[P], 53-5% CP) of the cases with AMCA had a cytogenetic, DNA based, or syndrome diagnosis leaving a significant minority of cases without a specific diagnosis. In a study of 1000 patients referred to a centre specialising in the treatment of craniofacial disorders, Shprintzen et all4 reported similar results with 41% of CL[P] and CP cases with AMCA having no specific diagnosis.
The CL[P]:CP ratio provides a convenient method for observing differences in subgroup distribution between populations. In European populations the average TBP is about 10/.. for CL[P] and 0-50/0. for Cpl°12 thus giving a predicted CL[P]:CP ratio of approximately 2. It is evident from the ratios derived from seven widely quoted reports (table 4) that the Scots and the Finns3' have significantly lower ratios than the rest of the group (p<0-01). Other Scottish2223 and Finnish'3 studies have shown similarly low CL[P]:CP ratios. As the overall TBP in these reports are similar, it would appear that the altered CL[P]:CP ratios in Scotland and Finland are the result of both "too many" CP cases and "too few" CL[P] cases. The CL[P]:CP ratio of those cases with facial cleft as an isolated congenital anomaly (ICA) and those with AMCA were also compared (table 4 ). The CL[P]:CP ratio in the ICA group in all the studies was found to be higher than that in either the combined group or the AMCA group; however, the ratio in the Finns and the Scots remain significantly below the European average (p < 0 01). Interestingly, the ICA CL[P]:CP ratio from the Hungarian population5 appears to be significantly higher (p < 00 1) than other reports.
There are three possible explanations for these results, none of which is mutually exclusive. Firstly the results could be artefactual, secondly, a specific environment influences the numbers of cases with AMCA and the CL[P]:CP ratio, and, thirdly, the differences are because of the populations being genetically heterogeneous. The studies chosen for comparison (table 4) used standard, multiple source techniques of ascertainment and were carried out by respected investigators so it would seem unlikely that the observed differences are the result of biased ascertainment.
Evidence that environmental or genetic factors or both may influence the CL[P]:CP ratio comes from a study in which Beckman and Myrberg37 observed that it varied inversely with latitude in Sweden. They found the ratio to be 1-46:1 in northern counties, 182:1 in central counties, and 3-72:1 in southern counties with similar TBP in each group. Thus the factors acting on the Scottish and Finnish populations producing low CL[P]:CP ratios may be a result of their location in northern latitudes. The lack of seasonal variation in both the present study and previous reports,3940 however, implies that any exogenic factors acting on these populations are not directly related to temperature, weather, or daylight effects. Although the identification of specific environmental factors acting on populations has proven difficult, the reduction in recurrence of facial clefts born to women who had taken periconceptional multivitamin sup-plementation4' may suggest an aetiological or corresponding role for dietary factors.
The regional differences in CL[P]:CP ratio and the proportion of facial cleft cases with AMCA could also reflect genetic differences in these populations. The prospect of elucidating such hereditary factors involved in facial clefting has been enhanced by the discovery of an association between both isolated CL[P] and CP and a genetic variation in the TGF a gene.182' It may be possible in the future to show genetic differences between facial cleft groups in different populations that will explain the CL[P]:CP ratio using this or other candidate gene probes. We are currently undertaking such a study in our population.
In conclusion, we cannot explain the differences in subgroup ratios and associated abnormalities found in European populations; however, it would appear that the commonly held assumption that there is little or no variation in the birth prevalence of CP9'°is incorrect. To advance our understanding of the constellation of abnormalities that are associated with facial clefts it will be necessary to collect a large, well documented cohort of patients with facial clefts as part of multiple congenital anomalies in the hope that new diagnostic categories could be identified. This will certainly be a useful future role for projects such as the EUROCAT registers. Facial clefts have been one of the most intensely studied of human malformations with almost every report raising more questions than it has answered. This study follows the tradition and we hope that it will stimulate further research.
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